During the past twenty years, the American Foundation for Suicide Prevention and American psychiatry have adopted a "medicalized" approach to preventing suicide, claiming that antidepressants are protective against suicide. Yet, the suicide rate in the United States has increased 30% since 2000, a time of rising usage of antidepressants. A review of studies of the effects of mental health treatment and antidepressants on suicide reveals why this medicalized approach has not only failed, but pushed suicide rates higher.
Author William Styron is often remembered for speaking about depression as an illness. But a review of his life reveals that psychiatric drugs may have triggered and even worsened his depressive episodes.
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.
Tony Kendrick, a professor of Primary Care at the University of Southampton, has found through his research and practice that too many people are being prescribed antidepressants long-term without the information and support necessary to get off of them.
The Ministry of Health in Norway has ordered its four regional health authorities to offer medicine-free treatment in psychiatric hospitals. A six-bed ward in Tromso, which is in the far north of Norway, is now providing such care.
In Israel, there is a budding Soteria movement that foretells of a possible paradigm shift in care. The thought is that such care may become a first-line treatment for newly psychotic patients.
Disability Rights California will challenge Los Angeles’ Assisted Outpatient Treatment program in court this fall, DRC attorney Pamela Cohen announced Friday. According to Cohen, California’s AB-1241 or “Laura’s Law” diverts funding from community mental health services and towards police, administrators and courts, doesn’t reach the people it purports to be trying to help, and violates people’s civil rights. “This is an illegal program,” said Cohen.
Part two of a Mad In America investigation into the expansion of psychological screening and electronic surveillance of children and youth. Experts point to mounting evidence that scientifically dubious mental health screening programs are just one part of an international governance shift towards creating all-pervasive surveillance systems for diagnosing 'pre-crime' and managing 'at-risk' children and youth. And not only is this not helping kids, critics argue, it’s demonstrably harming them.
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.
In the past five years, there has been a dramatic explosion of interest in the Open Dialogue Therapy practiced in Tornio, Finland. It is a humanistic “treatment” that has produced five-year outcomes for psychotic patients that are, by far, the best in the developed world, and there are now groups in the United States, Europe and beyond that are seeking to “import” this care. However, the challenges for doing so are many and, last month, Open Dialogue UK - on the occasion of the first-ever fully recognized Open Dialogue training outside of Tornio - organized a conference in London to hold an open dialogue about Open Dialogue.
Dr. Vance Trudeau discusses his study's finding that antidepressants may have far-reaching, adverse effects that last up to three generations.
Lancet Psychiatry, a UK-based medical journal, recently published a study that concluded brain scans showed that individuals diagnosed with ADHD had smaller brains. That conclusion is belied by the study data. The journal needs to retract this study. UPDATE: Lancet Psychiatry (online) has published letters critical of the study, and the authors' response, and a correction.
The Law Project for Psychiatric Rights is eager to provide advice or assistance to US citizens who may wish to sue their physicians for prescribing off-label psychiatric drugs to children, said lawyer James Gottstein in an interview with Mad In America.
Through years of turmoil and confusion, Cindi Fisher’s enduring love for her involuntarily committed son gradually changed her from compliant mom to mental health civil rights activist. That’s when authorities banned her from even contacting her son. But could she be a bellwether of a coming nation-wide wave of protestors?
In a MIA survey of people who had been patients in mental hospitals, nearly 500 respondents told of an experience that was often traumatic, and frequently characterized by a violation of their legal rights, forced treatment with drugs, and physical or sexual abuse. Only 17% said they were “satisfied” with the “quality of the psychiatric treatment” they received.
Dr. Raskin discusses psychotherapists’ dissatisfaction with current psychiatric diagnostic systems and explores alternatives.
Part one of a two-part Mad In America investigation into the expansion of psychological screening and electronic surveillance of children and youth. A new government-funded mental health training program for British Columbia family physicians and school staff promotes screening for mental disorders in all children and youth. Critics say the program omits key scientific evidence, seems more like drug promotion than medical education, and downplays serious potential harms. Nevertheless, programs like it are rolling out across Canada and the US.
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.
After a meta-analysis of RCTs of antidepressants was published in Lancet, psychiatry stated that it proved that "antidepressants" work. However, effectiveness studies of real-world patients reveal the opposite: the medications increase the likelihood that patients will become chronically depressed, and disabled by the disorder.
The published report of the Broaden Trial of Deep Brain Stimulation for Depression whitewashed the results: although the efficacy results were negative, the investigators concluded that the therapy still showed "promise", and adverse events suffered by the patients were downplayed or attributed to the disease, and not the treatment. An in-depth investigation of how the trial results were spun, and interviews with patients that tell of harm done.
The International Society for Ethical Psychology and Psychiatry had the clout to draw a stellar line-up of presenters to its recent conference, including internationally prominent critics like David Healy, Peter Gøtzsche, Robert Whitaker and Allen Frances. There were lots of learnings and even some tense discussions, but one of the most intriguing aspects of the entire conference was the way in which scientific and social issues became deeply intertwined, especially when presenters reached for better pathways forward.